Molnupiravir Matching placebo tablets, molnupiravir
MK-4482-023
Phase 3 small_molecule active
Quick answer
Molnupiravir Matching placebo tablets, molnupiravir for SARS-CoV-2 (COVID-19) infection is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- SARS-CoV-2 (COVID-19) infection
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active